Abstract
An inverse relationship exists between the expression of 15-lipoxygenase-2 (15-LOX-2) and peroxisome proliferator-activated receptor γ (PPARγ) in normal prostate epithelial cells (PrECs) compared with their expression in prostate carcinoma cells (PC-3). The reason for this difference, however, is unknown. We hypothesized that this inverse expression partly involves the 15-LOX-2 promoter and 15-S-hydroxyeicosatetraenoic acid (15-(S)-HETE), a product of 15-LOX-2 that binds to PPARγ. We identified an active steroid nuclear receptor half-site present in the 15-LOX-2 promoter fragment F-5 (-618/+177) that can interact with PPARγ. After forced expression of wild-type PPARγ, 15-(S)-HETE (1 μM) decreased F-5 reporter activity in PrECs whereas forced expression of 15-LOX-2 resulted in 15-(S)-HETE production which enhanced F-5 activity in PC-3. In contrast, the expression of dominant-negative PPARγ reversed the transcriptional activation of F-5 by enhancing it 202-fold in PrEC or suppressing it in PC-3; the effect in PC-3 was positively increased 150-fold in the presence of 15-(S)-HETE (1 μM). Peroxisome proliferator-activated receptor γ interacted with 15-LOX-2 promoter sequences in pulldown experiments using biotinylated 15-LOX-2 (-560/-596 bp) oligonucleotides. In gelshift analyses PPARγ and orphan receptor RORα were shown to interact with the F-5 fragment in PC-3 cells. These data suggest that crosstalk mechanisms exist between the 15-LOX-2 gene and PPARγ to counterbalance expression and help explain the inverse relationship of these genes in normal versus cancer cells.
Original language | English (US) |
---|---|
Pages (from-to) | 6015-6025 |
Number of pages | 11 |
Journal | Oncogene |
Volume | 25 |
Issue number | 44 |
DOIs | |
State | Published - Sep 28 2006 |
Keywords
- 15-lipoxygenase-2
- Gene expression
- Peroxisome proliferator-activated receptor γ
- Prostate cancer
ASJC Scopus subject areas
- Molecular Biology
- Genetics
- Cancer Research